The downregulation of P53 and P21 expression through the IL-6/JAK2/STAT pathway could upregulate DNMT1, enhance tumor initiation, and promote lung cancer stem cell proliferation (Liu et al., 2015). The gene discussed is IL6; the disease is lung carcinoma.